Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          HHS Search block
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations Breadcrumb
    Home
                              Blog
                              Readout: CDC and OASH’s Office of Science and Medicine Host Roundtable on Vector-Borne Disease National Strategy
 Navigate to:
  Categories
    Coronavirus (12)
        Health IT (13)
        Fraud (1)
        Grants and Contracts (1)
        Research (5)
        Prevention and Wellness (21)
        Health Data (6)
        Holidays and Observances (17)
        Global Health (4)
        Public Health and Safety (28)
        HIPAA (4)
        Programs for Families and Children (6)
        Americans with Disabilities Act (1)
        Mental Health and Substance Abuse (1)
        Vaccines (1)
        HHS Administrative (4)
        LGBT (1)
        Emergency Preparedness and Response (1)
        Drug Pricing (5)Text resize icon

                    




Readout: CDC and OASH’s Office of Science and Medicine Host Roundtable on Vector-Borne Disease National Strategy








  
  
    

  
      
**May 29, 2024**
                |
        By:  Daniel    Desautels  PhD, Health Scientist, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Deanna    Lebel   MHS, ORISE Fellow, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services and Kristen    Honey  PhD, PMP, Chief Data Scientist, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services

  
**Summary:**
  





CDC and OASH host a hybrid roundtable to hear from members of the public on priorities for implementing the Vector-Borne Disease National Strategy


      As part of ongoing public engagement on vector-borne diseases, on Thursday, May 23, 2024, the Centers for Disease Control and Prevention (CDC) and the Office of the Assistant Secretary for Health’s (OASH) Office of Science and Medicine met with researchers, clinicians, public health officials, vector control officials, and patients and patient advocates to hear about public priorities for implementing the goals from the recently published *National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People* *(VBD National Strategy)*. The *VBD National Strategy* was developed by the Department of Health and Human Services (HHS) in response to congressional direction in the 2019 Kay Hagan Tick Act (42 U.S.C. §§ 247b-23 and 300hh-32) asking the HHS Secretary to ensure the development and implementation of a national strategy to address the growing concern of vector-borne diseases. The primary purpose of the meeting is to increase awareness of the *VBD National Strategy* and inform future implementation efforts.The roundtable featured over 120 invited participants, participating in-person at HHS headquarters in Washington, D.C., and virtually in Zoom breakout rooms. The event provided a hybrid venue to hear a set of lightning talks from federal agency representatives on 2023 vector-borne disease prevention and control efforts. It also provided a space to hear diverse perspectives on goals and priorities for implementing the *VBD National Strategy*. Both the opening and closing sessions featured on HHS live streaming will be available on HHS YouTube in the coming weeks. Invited participants with a range of vector-borne disease experience participated in a set of interactive activities to collect individual opinions on priority areas of focus for *VBD National Strategy* Implementation.The day began by both Dr. Lyle Petersen, Director of the Division of Vector-Borne Diseases, CDC, and Dr. Leith States, Acting Deputy Assistant Secretary for Science and Medicine, OASH, highlighting the growing health threat of vector-borne diseases in the United States. Both stressed the Department’s commitment to addressing those threats. Dr. Susanna Visser, Deputy Director for Policy and Extramural Program, DVBD, CDC provided an overview of the *VBD National Strategy* with five main goals and 19 strategic priorities to drive progress. Dr. Visser drew attention to the four audacious public health outcomes in the strategy, including a 25% reduction laboratory confirmed Lyme disease cases by 2035 compared to 2022.Following the strategy overview, Dr. Kristen Honey, Chief Data Scientist, OASH, HHS, thanked participants for sharing their candid feedback and underscored the need for VBD solutions to be “co-created” by everyone working together for maximum impact. Diverse representatives from participating agencies provided 5-minute lightning talks on success stories from their agencies in 2023, including the:HHS Lyme Innovation with the LymeX Diagnostics Prize competition;Rocky Mountain spotted fever prevention and control in Arizona tribal communities;Department of Defense MilTICK program;Flea control at Badlands National Park; andLonghorned tick emergence in the United States.The roundtable exercises, led by third-party facilitators, provided an open forum for all participants to provide candid feedback on the five goals and 19 strategic priorities of the *VBD National Strategy*. Participants placed stickers on posters of each of the five goals and 19 strategic priorities to demonstrate the most important priorities to them. Participants also had open discussions to provide context and nuance on their perspectives, captured by notetakers at each of six tables in person and six virtual breakout rooms. The roundtable event closed with a final session broadcast on HHS live to summarize the input collected from the day’s activities.Emerging themes included the need for better diagnostics for existing and novel VBDs, the inclusion of diverse voices and patient perspective in solutions to VBD threats, and the importance of improved clinician education on VBD diagnosis and treatment. The third-party facilitators are collecting and summarizing the individual inputs from the roundtable to provide to the 17 federal agencies that developed the VBD National Strategy to help inform future implementation plans and updates to the *VBD National Strategy*. This post-event report from the Roundtable on *VBD National Strategy* will be available to the public when published later this year.The May 2024 Roundtable on *VBD National Strategy* kicks off the beginning of implementing the *VBD National Strategy* with collaboration within and outside the federal government. Together, the collective vision is a nation where vector-borne diseases no longer threaten human health and well-being. For more information please visit https://www.hhs.gov/ash/osm/innovationx/vector-borne-disease-national-strategy/index.html or email vectorbornedisease@hhs.gov.
  Posted In:
  Public Health and SafetySign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up







  Subscribe to RSS
    

      Receive latest updates

                    
  


Related Blog Posts
    

      Change Story: Cheryl R. Campbell
  

Change Story: Tiffany Brown
  

Change Story: Robin D. Bailey Jr. Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​ Disclaimer Policy: Links with this icon () mean that you are leaving the HHS website. The Department of Health and Human Services (HHS) cannot guarantee the accuracy of a non-federal website.
                  Linking to a non-federal website does not mean that HHS or its employees endorse the sponsors, information, or products presented on the website. HHS links outside of itself to provide you with further information.
                  You will be bound by the destination website's privacy policy and/or terms of service when you follow the link.
                  HHS is not responsible for Section 508 compliance (accessibility) on private websites. For more information on HHS's web notification policies, see Website Disclaimers.
 Continue
                  Go back